Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seung Hwan Han

Showing results (181-190 of 222) with videos related to

Pageof 23
Sort By:
Clinical Therapeutics|March 23, 2025
A Phase III Randomized, Double-Blind, Active-Controlled, Multicenter Study on the Efficacy and Safety of Ezetimibe/Atorvastatin/Amlodipine Combination in Patients With Comorbid Primary Hypercholesterolemia and Essential HypertensionChan Joo Lee, Ji Yong Choi, Seung Hwan Han, et al.
BMC Cardiovascular Disorders|November 19, 2020
Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarctionPyung Chun Oh, Young Sil Eom, Jeonggeun Moon, et al.
Plos One|May 23, 2020
Prognostic impact of the combination of serum transaminase and alkaline phosphatase determined in the emergency room in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionPyung Chun Oh, Young Sil Eom, Jeonggeun Moon, et al.
The American Journal of Cardiology|January 31, 2025
Comparison of Provisional 1-Stent Strategy With Drug-Eluting Balloon Versus Planned 2-Stent Strategy in Patients With Non-LM Coronary True-Bifurcation Lesions (PROVISION-DEB)Sang-Suk Choi, Jin Jung, Kyunyeon Kim, et al.
JACC. Cardiovascular Interventions|May 25, 2015
The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation TestDong Il Shin, Sang Hong Baek, Sung Ho Her, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 1, 2011
Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trialWoong Chol Kang, Taehoon Ahn, Kyounghoon Lee, et al.
Journal of Clinical Medicine|August 7, 2021
Effect of Significant Coronary Artery Stenosis on Prognosis in Patients with Vasospastic Angina: A Propensity Score-Matched AnalysisHyun-Jin Kim, Min-Ho Lee, Sang-Ho Jo, et al.
Scientific Reports|November 30, 2019
Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center CohortSeong-Sik Cho, Sang-Ho Jo, Seung Hwan Han, et al.
Atherosclerosis|January 19, 2019
Impact of multi-vessel vasospastic angina on cardiovascular outcomeSeung Hwan Han, Kwan Yong Lee, Sung Ho Her, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 12, 2022
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trialKi-Chul Sung, Jung Hoon Sung, Eun Joo Cho, et al.
Pageof 23

Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
Clinical Therapeutics|March 23, 2025
A Phase III Randomized, Double-Blind, Active-Controlled, Multicenter Study on the Efficacy and Safety of Ezetimibe/Atorvastatin/Amlodipine Combination in Patients With Comorbid Primary Hypercholesterolemia and Essential HypertensionChan Joo Lee, Ji Yong Choi, Seung Hwan Han, et al.
BMC Cardiovascular Disorders|November 19, 2020
Addition of routine blood biomarkers to TIMI risk score improves predictive performance of 1-year mortality in patients with ST-segment elevation myocardial infarctionPyung Chun Oh, Young Sil Eom, Jeonggeun Moon, et al.
Plos One|May 23, 2020
Prognostic impact of the combination of serum transaminase and alkaline phosphatase determined in the emergency room in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionPyung Chun Oh, Young Sil Eom, Jeonggeun Moon, et al.
The American Journal of Cardiology|January 31, 2025
Comparison of Provisional 1-Stent Strategy With Drug-Eluting Balloon Versus Planned 2-Stent Strategy in Patients With Non-LM Coronary True-Bifurcation Lesions (PROVISION-DEB)Sang-Suk Choi, Jin Jung, Kyunyeon Kim, et al.
JACC. Cardiovascular Interventions|May 25, 2015
The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation TestDong Il Shin, Sang Hong Baek, Sung Ho Her, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 1, 2011
Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trialWoong Chol Kang, Taehoon Ahn, Kyounghoon Lee, et al.
Journal of Clinical Medicine|August 7, 2021
Effect of Significant Coronary Artery Stenosis on Prognosis in Patients with Vasospastic Angina: A Propensity Score-Matched AnalysisHyun-Jin Kim, Min-Ho Lee, Sang-Ho Jo, et al.
Scientific Reports|November 30, 2019
Clopidogrel plus Aspirin Use is Associated with Worse Long-Term Outcomes, but Aspirin Use Alone is Safe in Patients with Vasospastic Angina: Results from the VA-Korea Registry, A Prospective Multi-Center CohortSeong-Sik Cho, Sang-Ho Jo, Seung Hwan Han, et al.
Atherosclerosis|January 19, 2019
Impact of multi-vessel vasospastic angina on cardiovascular outcomeSeung Hwan Han, Kwan Yong Lee, Sung Ho Her, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 12, 2022
Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trialKi-Chul Sung, Jung Hoon Sung, Eun Joo Cho, et al.
Pageof 23